IP Verse

Compositions And Methods Of Treating Inflammatory And Autoimmune Diseases

Patent No. EP2382228 (titled "Compositions And Methods Of Treating Inflammatory And Autoimmune Diseases") was filed by Amgen on Jan 20, 2010. The application was issued on Aug 26, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
KONIG SZYNKA TILMANN VON RENESSEMay 26, 2021KONIG SZYNKA TILMANN VON RENESSE DUSSELDORF
KONIG SZYNKA TILMANN VON RENESSEMay 26, 2021KONIG SZYNKA TILMANN VON RENESSE PATENTANWALTE PARTNERSCHAFT MBB DUSSELDORF
MERCK SHARP & DOHMEMay 26, 2021MERCK SHARP & DOHME
SANOFIMay 25, 2021CABINET NONY
SANOFIMay 25, 2021IPSILON
STRAWMANMay 25, 2021MEWBURN ELLIS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2382228

AMGEN
Application Number
EP10733814A
Filing Date
Jan 20, 2010
Status
Granted And Under Opposition
Jul 24, 2020
Publication Date
Aug 26, 2020
External Links
Slate, Register , Google Patents